首页> 外文期刊>Journal of Epidemiology & Community Health >Adult asthma increases dementia risk: a nationwide cohort study
【24h】

Adult asthma increases dementia risk: a nationwide cohort study

机译:成人哮喘增加痴呆风险:一项全国性队列研究

获取原文
获取原文并翻译 | 示例
       

摘要

Background Studies on the association between adult asthma and dementia are few. We investigated the risk of dementia in patients diagnosed with adult asthma compared with that of people without asthma who were age and sex matched to the study patients. Methods We used data from the National Health Insurance Research Database. A total of 12 771 patients with newly diagnosed asthma between 2001 and 2003 were evaluated and 51 084 people without asthma were used as the comparison cohort. Cox proportional hazard regression analysis was used to measure the HR of dementia for the asthmatic cohort, compared with that of the non-asthmatic cohort. Results The HR of dementia was 1.27 (95% confidence interval (CI) 1.15 to 1.41) for the asthmatic cohort, compared with the non-asthmatic cohort after adjusting for age, sex, comorbidities, annual outpatient department visits and medicine used. The HR of dementia development increased substantially as frequency of asthma exacerbation and hospitalisation increased. Conclusions This nationwide cohort study suggests that the risk of dementia development is significantly increased in patients with asthma compared with that of the general population. In addition, dementia risk increases substantially with asthma exacerbation and hospitalisation frequency increases.
机译:关于成人哮喘与痴呆症之间关联的背景研究很少。我们调查了诊断为成人哮喘的患者与年龄和性别相匹配的无哮喘患者的痴呆风险。方法我们使用了来自国家健康保险研究数据库的数据。在2001年至2003年期间,共对12 771例新诊断为哮喘的患者进行了评估,并将51 084人无哮喘作为比较队列。与非哮喘人群相比,使用Cox比例风险回归分析来测量哮喘人群的痴呆HR。结果调整了年龄,性别,合并症,每年门诊就诊次数和所用药物后,哮喘人群的痴呆HR为1.27(95%置信区间(CI)1.15至1.41),而非哮喘患者为HR。随着哮喘发作和住院频率的增加,痴呆症发展的HR显着增加。结论这项全国性队列研究表明,与普通人群相比,哮喘患者患痴呆症的风险显着增加。另外,痴呆的风险随着哮喘的加重而大大增加,住院频率也增加。

著录项

  • 来源
    《Journal of Epidemiology & Community Health》 |2015年第2期|123-128|共6页
  • 作者单位

    Department of Respiratory Therapy, China Medical University Hospital, Taichung, Taiwan,China Medical University, Taichung, Taiwan;

    China Medical University, Taichung, Taiwan,Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan;

    Department of Internal Medicine, Section of Respiratory Therapy, Changhua Christian Hospital, Changhua, Taiwan;

    China Medical University, Taichung, Taiwan,Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan;

    Management Office for Health Data, China Medical University Hospital, Taichung, Taiwan,Institute of Clinical Medical Science and School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan;

    Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan,Department of Respiratory Therapy, China Medical University, Taichung, Taiwan;

    Institute of Clinical Medical Science and School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan,Department of Nuclear Medicine and PET Center, China Medical University Hospital, Taichung, Taiwan,Institute of Clinical Medical Science, College of Medicine, China Medical University, No. 2, Yuh-Der Road, Taichung 40447, Taiwan;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 01:07:48

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号